Laurus Investment Counsel Inc. - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 231 filers reported holding BALCHEM CORP in Q2 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
Laurus Investment Counsel Inc. ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$3,342,174
-6.4%
19,9900.0%1.40%
+9.5%
Q2 2023$3,571,218
+74.9%
19,990
+67.7%
1.28%
+75.9%
Q1 2023$2,041,482
+3.5%
11,9200.0%0.73%
-0.5%
Q4 2022$1,972,826
+33.3%
11,920
+34.2%
0.73%
+35.7%
Q3 2022$1,480,000
+28.5%
8,8800.0%0.54%
-2.5%
Q2 2022$1,152,000
-5.1%
8,8800.0%0.55%
+21.0%
Q1 2022$1,214,000
-36.6%
8,8800.0%0.46%
-7.7%
Q4 2021$1,914,000
+17.1%
8,8800.0%0.50%
+6.4%
Q3 2021$1,634,000
+13.0%
8,8800.0%0.47%
+5.0%
Q2 2021$1,446,000
+29.8%
8,8800.0%0.44%
+3.5%
Q1 2021$1,114,000
+8.9%
8,8800.0%0.43%
+7.8%
Q4 2020$1,023,000
+18.0%
8,8800.0%0.40%
-6.6%
Q3 2020$867,000
+3.0%
8,8800.0%0.43%
-5.5%
Q2 2020$842,000
-4.0%
8,8800.0%0.45%
-28.9%
Q1 2020$877,000
-2.8%
8,8800.0%0.63%
+24.6%
Q4 2019$902,000
-45.2%
8,880
-46.4%
0.51%
-54.4%
Q3 2019$1,645,000
-0.8%
16,5800.0%1.12%
-4.7%
Q2 2019$1,658,000
+28.7%
16,580
+19.5%
1.17%
+16.3%
Q1 2019$1,288,000
+490.8%
13,880
+399.3%
1.01%
+396.6%
Q4 2018$218,000
-30.1%
2,7800.0%0.20%
-9.4%
Q3 2018$312,000
+14.3%
2,7800.0%0.22%
+14.9%
Q2 2018$273,000
+20.3%
2,7800.0%0.20%
+0.5%
Q1 2018$227,000
+1.3%
2,7800.0%0.19%
+7.8%
Q4 2017$224,0002,7800.18%
Other shareholders
BALCHEM CORP shareholders Q2 2018
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 203,004$25,18119.44%
Montanaro Asset Management Ltd 188,000$23,319,5204.10%
Conestoga Capital Advisors, LLC 1,076,327$133,507,6482.29%
GENEVA CAPITAL MANAGEMENT LLC 763,326$94,682,9372.00%
Tributary Capital Management, LLC 139,116$17,255,9491.63%
WASATCH ADVISORS LP 1,976,930$245,218,3971.55%
Cutter & CO Brokerage, Inc. 41,853$5,191,4091.52%
Laurus Investment Counsel Inc. 19,990$3,342,1741.40%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 37,950$4,707,3180.97%
MOODY ALDRICH PARTNERS LLC 36,613$4,541,4770.86%
View complete list of BALCHEM CORP shareholders